We are live on ! Find out more
ANVS icon

Annovis Bio
ANVS

56 hedge funds and large institutions have $10.5M invested in Annovis Bio in 2026 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

136% more call options, than puts

Call options by funds: $1.03M | Put options by funds: $438K

56% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 9

30% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 10

6% more funds holding

Funds holding: 53 → 56 (+3)

0.66% more ownership

Funds ownership: 15.99% → 16.65% (+0.66%)

28% less capital invested

Capital invested by funds: $14.7M → $10.5M (-$4.14M)

Holders
56
Holders Change
+3
Holders Change %
+5.66%
% of All Funds
0.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
13
Reduced
10
Closed
9
Calls
$1.03M
Puts
$438K
Net Calls
+$597K
Net Calls Change
-$647K

Top Buyers

Rank Fund Capital Flow
1
Marshall Wace
Marshall Wace
United Kingdom
+$1.27M
2
Renaissance Technologies
Renaissance Technologies
New York
+$953K
3
Two Sigma Investments
Two Sigma Investments
New York
+$208K
4
GCP
GSA Capital Partners
United Kingdom
+$125K
5
SG
Sherry Group
Arkansas
+$82.3K

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$689K
2
DADC
D.A. Davidson & Co
Montana
-$556K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$233K
4
OAC
OMERS Administration Corp
Ontario, Canada
-$215K
5
VF
Virtu Financial
New York
-$91K
Name Holding Trade Value Shares
Change 		Change in
Stake
RSWM
26
Robertson Stephens Wealth Management
California
$41.4K – – –
CAMG
27
CWA Asset Management Group
Florida
$37.9K – – –
Bank of New York Mellon
28
Bank of New York Mellon
New York
$34.5K -$12.6K -4,582 -23%
Koshinski Asset Management
29
Koshinski Asset Management
Illinois
$33.5K +$49 +18 +0.1%
Wells Fargo
30
Wells Fargo
California
$31.9K – – –
JP Morgan Chase
31
JP Morgan Chase
New York
$29.9K – – –
VGA
32
Vanguard Global Advisers
Pennsylvania
$25K +$30.7K +11,190 New
RWM
33
RKL Wealth Management
Pennsylvania
$22.3K – – –
WSFS
34
Wilmington Savings Fund Society
Delaware
$20.9K – – –
Morgan Stanley
35
Morgan Stanley
New York
$12.8K -$11.4K -4,168 -42%
GCM
36
Gallacher Capital Management
Colorado
$12.7K +$15.6K +5,705 New
AAP
37
Arax Advisory Partners
Colorado
$8.92K +$8.23K +3,000 +300%
C
38
Covestor
United Kingdom
$5K +$16 +6 +0.3%
CA
39
CoreCap Advisors
Michigan
$4.68K +$5.76K +2,101 New
SS
40
SBI Securities
Japan
$3.39K -$14 -5 -0.3%
KFAS
41
Keating Financial Advisory Services
Kansas
$2.41K +$2.97K +1,082 New
DPW
42
DiNuzzo Private Wealth
Pennsylvania
$2.23K – – –
Rockefeller Capital Management
43
Rockefeller Capital Management
New York
$2.23K – – –
TRCT
44
Tower Research Capital (TRC)
New York
$2.1K -$34.9K -12,718 -93%
FIA
45
FNY Investment Advisers
New York
$2K -$2.74K -1,000 -50%
BF
46
BOK Financial
Oklahoma
$1.24K +$1.52K +555 New
MCM
47
MAI Capital Management
Ohio
$1.11K +$1.37K +500 New
PNC Financial Services Group
48
PNC Financial Services Group
Pennsylvania
$803 – – –
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$780 – – –
LFG
50
Larson Financial Group
Missouri
$669 – – –
1
2
3

ANVS Hedge Fund Activity: Q1 2026 in Review

56 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in Annovis Bio (ANVS) for Q1 2026, worth a combined $10.5M — down 28% from $14.7M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new ANVS positions and 9 closed out — a net gain of 5 holders — while 13 added to existing stakes and 10 trimmed.

The largest buyer was Marshall Wace, adding an estimated $1.27M. The largest seller was Jane Street, exiting entirely with an estimated $689K sold.

  • 56 institutional investors held Annovis Bio (ANVS) as of Q1 2026, up from 53 in Q4 2025.
  • Funds reported $10.5M of Annovis Bio stock for Q1 2026, down 28% quarter-over-quarter.
  • 14 funds opened new Annovis Bio positions in Q1 2026 and 9 closed out, a net change of +5 holders.
  • The largest Annovis Bio buyer in Q1 2026 was Marshall Wace, an estimated $1.27M added.
  • The largest Annovis Bio seller in Q1 2026 was Jane Street, an estimated $689K sold.

Based on aggregated 13F filings for Q1 2026.